Inhibition of p38 or MK2 Increases SMAC-Mimetic Efficacy against AML [Leukemia]

The loss of p38 or MK2 enhances SMAC-mimetic–mediated TNF production and cytotoxicity.

from Cancer via ola Kala on Inoreader http://ift.tt/1qiynnw
via IFTTT